Illumaxbio, a leading developer of medical diagnostic technologies, is pleased to announce that four of its revolutionary CLEIA systems and 60 accompanying single-use chemiluminescence immunoassay reagent kits have earned CE certification. The products have been designed and engineered to provide unparalleled speed, reliability, and accuracy, meeting the highest international standards of safety and efficiency.
CLEIA systems have been at the forefront of medical diagnostic technology, with their ability to help detect medical conditions with high specificity and sensitivity. Illumaxbio’s advanced CLEIA systems – lumilite8, lumilite8s, lumiflx16, and lumiflx16s – have completed IVDR CE registration, ensuring customers around the world receive only the highest quality products.
As Europe transitions from IVDD to IVDR CE regulations, Illumaxbio has demonstrated a commitment to customer satisfaction by complying with the latest regulations. In clinical settings, rapid and accurate diagnosis and treatment of medical conditions is crucial, and the innovative CLEIA systems from Illumaxbio can be trusted to provide results that help clinicians prospectively identify those who may require more aggressive treatment strategies.
The 60 accompanying single-use chemiluminescence immunoassay reagent kits have also completed IVDD CE registration, providing rapid and user-friendly results for a range of medical conditions, including cardiac, inflammatory, tumor markers, reproductive, prenatal screening, and thyroid function, among others. These reagent kits have been designed for single-use, allowing for easy integration into hospitals and clinics, improving the overall workflow of clinical personnel.
As a medical diagnostic technology leader, Illumaxbio will continue to invest in research and development to meet the needs of customers worldwide. The goal remains to provide easy-to-use diagnostic solutions that deliver dependable results, ultimately guiding clinicians toward more rapid and accurate treatment strategies for their patients.
The CEO and Management Team of Illumaxbio would like to congratulate their team of world-class engineers and scientists on achieving CE certification for these innovative and life-saving systems. The unprecedented speed, accuracy, and reliability of these systems and reagents are a testament to the dedication, expertise, and hard work of everyone involved.
Post time: Jun-08-2023
